NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coty-inc-class-action. Why Is Coty being Investigated?Coty is one of the world’s largest beauty companies with a portfolio of brands across fragrance, color cosmetics, and skin and b ...

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations [3]. - The company's stock price fell by $1.05 per share, a decline of over 21%, from $4.86 on August 20, 2025, to $3.81 on August 21, 2025, following the announcement of these results [3]. Group 3: Market Dynamics - Coty indicated that retailers were maintaining tight inventory levels, while in reality, they were overstocked due to a decline in demand for Coty's products [2]. - The company experienced a slowdown in cosmetics sales attributed to value-seeking consumer behavior, fatigue with innovation, and specific U.S. factors such as in-store security measures and immigration policy changes [3].

PARIS — What will it mean for Coty Inc. when it loses the Gucci fragrance in 2028? Analysts are speculating about just that hours after it was announced Sunday night that L’Oréal now has the rights to enter into a 50-year exclusive license for the creation, development and distribution of fragrance and beauty products for Gucci, starting in 2028, when Coty’s license with Kering expires. More from WWD That is part of the 4-billion-euro deal revealed between L’Oréal to acquire Kering Beauty and forge a stra ...

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products [2]. - Prestige fragrances represent 60% of Coty's revenues, indicating a significant reliance on this segment [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution and retailer inventory buildup [3]. - The company's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share following the announcement of these results [3]. Group 3: Market Dynamics - Coty claimed strong demand for its Prestige fragrances, but evidence suggests that retailers were actually overstocked due to declining demand for Coty's products [2]. - The company faced a slowdown in cosmetics sales attributed to value-seeking consumer behavior and specific U.S. market challenges [3].

Core Insights - Coty Inc. has initiated a strategic review of specific assets within its Consumer Beauty division, exploring options such as sales, spin-offs, or other strategic transactions [2][3][8] - The review includes Coty's mass color cosmetics portfolio, generating approximately $1.2 billion in annual revenue, and its Brazil business, which contributes close to $400 million in annual revenue [3][8] - The remaining Coty entity aims to strengthen its position in the global fragrance market by integrating its Prestige Beauty and Mass Fragrance businesses, which together account for around 69% of total sales [4][12] Financial Performance - In fiscal year 2025, total revenue fell 3.7% year-over-year to $5.9 billion, with Consumer Beauty revenue declining 8.3% to $2.1 billion [21][22] - The adjusted EBITDA for FY25 decreased by 0.9% year-over-year to $1,082 million, while adjusted net income declined 41.6% to $188.8 million [22][23] - The Consumer Beauty segment's like-for-like revenue declined by 5% in FY25, contrasting with the flat performance of the Prestige fragrance segment [13][19] Strategic Rationale - The strategic review is driven by the underperformance of the Consumer Beauty division compared to the Prestige division, which has seen stronger growth [8][12] - Coty aims to optimize its brand portfolio and focus on higher-margin segments, as the global luxury perfume market is projected to grow from $52 billion in 2025 to $79.5 billion by 2030, representing a CAGR of 8.9% [12][14] - The initiative aligns with the investment strategy of Coty's controlling shareholder, JAB Holding Company, which focuses on divesting noncore assets to enhance value [14][15] Organizational Changes - Coty has appointed Gordon von Bretten as President of the Consumer Beauty division to drive mass cosmetics and personal care businesses [6] - Citibank is advising Coty on potential transaction options, including a spinoff or divestiture [7]

Roche's Genentech on Thursday said it will sell its flu pill, Xofluza, directly to certain patients at a discount in a bid to expand access, becoming the latest company to wade into the direct-to-consumer space. It follows similar moves by other drugmakers to simplify how Americans get their medicines, and comes as companies face pressure from the Trump administration to lower U.S. drug prices. Genentech's new program also launches ahead of the flu season, which typically peaks in the winter months. The 202 ...

ToplineThe youngest sibling of the generation of the Kardashian-Jenner family that rose to stardom released her first song Tuesday under the decade-old moniker “King Kylie” that she once used to help launch her billion-dollar cosmetics company and cement her relationship with rapper Tyga. Kylie Jenner at the Miu Miu fashion show on Oct. 6, 2025 in Paris, France.WWD via Getty ImagesKey FactsKylie Jenner, 28, released "Fourth Strike" with pop duo Terror Jr at midnight on Tuesday under the name "King Kylie," a ...

Key Takeaways Coty's Consumer Beauty segment saw an 8% sales drop and a $127M operating loss for fiscal 2025.Weakness in color cosmetics and body care offset gains in fragrances and skincare categories.Coty plans to refocus on profitability, innovation and higher-margin product launches.Coty Inc.’s ((COTY) Consumer Beauty segment ended fiscal 2025 on a downbeat note, with sales falling 8% year over year and operating profits slipping sharply as it contended with continued weakness in mass color cosmetics. T ...

Core Viewpoint - Coty Inc. is undergoing a significant strategic restructuring, focusing on a comprehensive evaluation of its mass beauty business to maximize long-term value and optimize asset allocation [1][2] Group 1: Business Overview - Coty Inc. was founded in 1904 in Paris and operates a range of iconic brands across fragrance, makeup, skincare, and body care, selling in over 120 countries [2] - The mass beauty segment, valued at $1.2 billion, includes brands such as CoverGirl, Rimmel, Sally Hansen, and Max Factor, with a nearly $400 million revenue contribution from Brazil [2][3] Group 2: Financial Performance - For the fiscal year ending June 30, 2025, Coty reported net revenues of $5.893 billion, a year-over-year decline of 3.68%, and a net loss of $381 million, compared to a profit of $76.2 million in the previous year [4] - The mass beauty segment experienced a revenue drop of 8% year-over-year, generating $2.073 billion in the same fiscal year [4][5] Group 3: Market Challenges - The mass beauty business has faced ongoing challenges, including a significant decline in the U.S. market, exacerbated by retailer inventory reductions and overall market pressures [4][5] - Coty has recorded a continuous decline in mass beauty revenues over four consecutive quarters, with Q1, Q2, and Q3 revenues of approximately $555 million, $554 million, and $470 million, respectively, reflecting year-over-year decreases of 3%, 8%, and 9.4% [6] Group 4: Organizational Changes - Coty is implementing organizational changes to integrate its high-end beauty and mass fragrance businesses, which together account for 69% of the company's sales [3][4] - The company has appointed Gordon von Bretten as president of the mass beauty division to explore potential in mass cosmetics, skincare, and personal care, while leading the strategic review [6]

Group 1 - Coty Inc. (NYSE:COTY) is considered one of the best penny stocks to buy according to hedge funds, with a Buy rating from RBC Capital analyst Nik Modi on October 3 [1] - On October 1, Canaccord Genuity analyst Susan Anderson reiterated a Hold rating with a price target of $4.00, while Bank of America Securities and Barclays maintained Sell ratings with a price target of $3.5 [2] - Coty operates a portfolio of brands in color cosmetics, fragrance, and skin and body care, including luxury brands like Gucci, Marc Jacobs, and Kylie Cosmetics [3] Group 2 - Coty's mass beauty products are primarily sold through various retail channels, including supermarkets, hypermarkets, drugstores, and e-commerce retailers [4]